Journey Medical (DERM) Market Capitalization (2021 - 2026)

Journey Medical (DERM) has reported Market Capitalization for 6 consecutive years, with $194.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Market Capitalization rose 16.4% year-over-year to $194.7 million; the trailing twelve-month figure through Jun 2026 stood at $194.7 million (up 16.4% YoY), and the FY2025 full-year result was $163.0 million, up 104.07% from the prior year.
• Market Capitalization improved to $194.7 million in Q2 2026 per DERM's latest filing, from $128.1 million in the prior quarter.
• Across five years, Market Capitalization topped out at $194.7 million in Q2 2026 and bottomed at $28.0 million in Q1 2023.
• Historically, Market Capitalization has averaged $97.3 million across 5 years, with a median of $94.3 million in 2022.
• The sharpest annual moves came in 2023 and 2024: Market Capitalization plunged 66.58% in 2023, then jumped 293.9% in 2024.
• Over 5 years, Market Capitalization stood at $33.7 million in 2022, then soared by 212.0% to $105.0 million in 2023, then fell by 23.93% to $79.9 million in 2024, then soared by 104.07% to $163.0 million in 2025, then grew by 19.4% to $194.7 million in 2026.
• According to Business Quant data, Market Capitalization over the past three periods registered $194.7 million, $128.1 million, and $163.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.